EMULGEL FORMULATION PDF
April 20, 2020 | by admin
The present study aims at preparing an Emulgel formulation of Meloxicam using emulsifiers and various gelling agents along with the use of. PDF | Emulgel is one of the recent technologies in NDDS used for dual control release of emulsion and gel for topical use. The stability of. PDF | Topical therapies in cream, ointment, gel and lotion formulation, are an important component of dermatological therapeutic.
|Published (Last):||23 December 2016|
|PDF File Size:||7.44 Mb|
|ePub File Size:||9.31 Mb|
|Price:||Free* [*Free Regsitration Required]|
A study of shear and compression deformations on hydrophilic gels of tretinoin.
Formulation and emugel of topical preparations containing phenol and local vesicants. This study was conducted to develop an emulgel formulation of chlorphenesin CHL using 2 types of gelling agents: The Theory and Practice of Industrial Pharmacy.
Transdermal controlled release systems.
Optimization of chlorphenesin emulgel formulation
Blackwell Scientific Publications; Abstract This study was conducted to develop an emulgel formulation of chlorphenesin CHL using 2 types of gelling agents: Received Dec 31; Accepted May Stability studies showed that the physical appearance, rheological properties, drug release, and antifungal activity in all the prepared emulgels remained unchanged upon storage for 3 months. Preparation of an emulgel for treatment of aphthous ulcer on the basis of carbomers. Rheological studies revealed that the CHL emulgels exhibited a shear-thinning behavior with thixotropy.
Bioavailability of salbutamol sulphate from different suppository formulations. Support Center Support Center. The prepared emulgels were evaluated for their physical appearance, rheological behavior, drug release, antifungal activity, and stability. Author information Article notes Copyright and License information Disclaimer.
Analysis of data on the medicament release from ointments. Encyclopedia of Pharmaceutical Technology. The Complete Drug Reference. It was found that the emulsifying agent concentration had the most pronounced effect on the drug release from the emulgels followed by the oil phase concentration and finally the type of the emulyel agent. Lea and Febiger; Az J Pharm Sci.
Swarbrick J, Boylan JC, editors.
Egypt J Pharm Sci. Formulation and stability of chloramphenicol gel and emulgel. Medical Applications of Controlled Release. Marcel Dekker Inc; This article emulgek been cited by other articles in PMC.
There was a problem providing the content you requested
The influence of the type of the gelling agent and the concentration of both the oil phase and emulsifying agent on the drug release from the prepared emulgels was investigated using a 2 3 formukation design.
Published online Sep 1.
The Pharmaceutical Press; National Center for Biotechnology InformationU. As a general conclusion, it was suggested that the CHL emulgel formulation prepared with HPMC with the oil phase concentration in its low level and emulsifying agent concentration in its high level was the formula of choice since it showed the highest drug release and antifungal activity. Commercially available CHL topical powder was used for formulatipn.
The drug release from all the emulgels was found to follow diffusion-controlled mechanism. They also exhibited higher drug release and antifungal activity than the Formulwtion powder.
Development of a thermoreversible gel for controlled-release ocular delivery of diclofenac sodium.